Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

5-HT1A agonists induce central cholinergic antinociception

N Galeotti1, C Ghelardini, A Bartolini

  • 1Department of Preclinical and Clinical Pharmacology M. Aiazzi-Mancini, University of Florence, Italy.

Pharmacology, Biochemistry, and Behavior
|August 1, 1997
PubMed
Summary

The 5-HT1A agonists buspirone, gepirone, and 8-OH-DPAT demonstrate significant pain relief in mice. This antinociceptive effect is mediated by central cholinergic pathways, not opioid or GABAB receptors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The potent and selective adenosine A<sub>2A</sub>R antagonists P400 and P625 protect against symptoms in autoimmune experimental encephalomyelitis by attenuating neuroinflammation and demyelination.

Neuropharmacology·2026
Same author

Protection From Demyelination by the Novel Adenosine Dual A<sub>2A</sub>/A<sub>2B</sub> Receptor Antagonist P626 in EAE and Cultured Oligodendrocyte Precursor Cells.

Journal of cellular and molecular medicine·2025
Same author

The dual role of VEGF-A in a complex in vitro model of oxaliplatin-induced neurotoxicity: Pain-related and neuroprotective effects.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2025
Same author

Retraction of "Acetyl-l-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy" [Neuroscience 167(4) (2010) 1168-1174].

Neuroscience·2024
Same author

Disruption of the microbiota-gut-brain axis is a defining characteristic of the α-Gal A (-/0) mouse model of Fabry disease.

Gut microbes·2023
Same author

Persulfidation of mitoKv7.4 channels contributes to the cardioprotective effects of the H<sub>2</sub>S-donor Erucin against ischemia/reperfusion injury.

Biochemical pharmacology·2023

Area of Science:

  • Pharmacology
  • Neuroscience
  • Pain Research

Background:

  • 5-HT1A receptor agonists are investigated for their potential analgesic properties.
  • Understanding the mechanisms of novel analgesics is crucial for pain management.
  • Cholinergic pathways play a role in pain modulation.

Purpose of the Study:

  • To investigate the antinociceptive effects of buspirone, gepirone, and 8-OH-DPAT.
  • To elucidate the underlying neurochemical mechanisms of their analgesic action.
  • To determine if these effects involve cholinergic, opioid, or GABABergic systems.

Main Methods:

  • Administered 5-HT1A agonists (buspirone, gepirone, 8-OH-DPAT) to mice via intraperitoneal (i.p.) or intracerebroventricular (i.c.v.) routes.
  • Evaluated antinociception using hot-plate (thermal) and abdominal constriction (chemical) tests.

Related Experiment Videos

  • Tested the involvement of specific receptor systems and neurotransmitters using antagonists and depleting agents (atropine, hemicholinium-3, NAN 190, naloxone, CGP 35348, pertussis toxin).
  • Assessed motor coordination and exploratory behavior using rota-rod and hole board tests.

    • Main Results:

    • Buspirone, gepirone, and 8-OH-DPAT produced significant antinociception in both thermal and chemical pain models.
    • The antinociceptive effects were blocked by atropine, hemicholinium-3, and the 5-HT1A antagonist NAN 190.
    • These effects were not affected by naloxone, CGP 35348, or pertussis toxin.
    • NAN 190 did not alter morphine's analgesic effect.
    • No motor or cognitive impairment was observed at effective antinociceptive doses.

    Conclusions:

    • Buspirone, gepirone, and 8-OH-DPAT exert antinociceptive effects in mice.
    • The mechanism involves the central amplification of cholinergic transmission.
    • These 5-HT1A agonists represent a non-opioid pathway for pain relief.